medica glp 1 coverage Navigating Changes to GLP-1 Medication GLP-1 Trends: Access & Shortages,

Opioid Use Disorder Outcomes In another study by Wang, Volkow, and colleagues, which included roughly 33,000 individuals with Type 2 diabetes and opioid use disorder, semaglutide was associated with a 42-68% lower risk of opioid overdoses compared to other diabetes medications during the 1-year follow-up period (Wang et al., 2024b)

These are lifestyle modulating drugs used by diabetic patients and are not meant to be used the same way by healthy individuals

Rodbard HW, Rosenstock J, Canani LH, Deerochanawong C, Gumprecht J, Lindberg S, et al

Depending on clinical presentation, additional testing may include chest radiography, pulmonary function tests, echocardiography, or CT imaging

p = 0.001) (Supplementary Table 2)